This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 /Â 30Â days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Kalkhoran, S. B. et al. Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission. Cardiovas. Res. https://doi.org/10.1093/cvr/cvaa343 (2021)
Related article
Bonora, M. et al. Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles. Nat. Rev. Cardiol. 16, 33–55 (2019)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Robson, A. Hydralazine reduces myocardial infarct size. Nat Rev Cardiol 18, 232 (2021). https://doi.org/10.1038/s41569-021-00514-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-021-00514-7
This article is cited by
-
Toxic aldehyde-scavenging polypeptides mitigate secondary injury after spinal cord injury
Science China Materials (2023)